PO

Insulet

- NASDAQ:PODD
Last Updated 2024-04-23

Indeed Snapshot

Track Insulet reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 29th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 67.0 52.0 54.0 55.0 60.0 64.0 97.0 140.00 140.00 2.60 3.50 2.60 2.50 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 29th, 2022 12:26PM Aug 29th, 2022 12:26PM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 28th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 67.0 52.0 54.0 55.0 60.0 64.0 97.0 140.00 140.00 2.60 3.50 2.60 2.50 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 28th, 2022 05:26AM Aug 28th, 2022 05:26AM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 27th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 67.0 52.0 54.0 55.0 60.0 64.0 97.0 140.00 140.00 2.60 3.50 2.60 2.50 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 27th, 2022 04:45AM Aug 27th, 2022 04:45AM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 25th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 61.0 60.0 57.0 56.0 53.0 68.0 52.0 55.0 56.0 60.0 65.0 96.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 25th, 2022 09:25AM Aug 25th, 2022 09:25AM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 23rd, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 61.0 60.0 57.0 56.0 53.0 68.0 52.0 55.0 56.0 60.0 65.0 96.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 23rd, 2022 11:18AM Aug 23rd, 2022 11:18AM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 21st, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 68.0 52.0 54.0 55.0 60.0 65.0 95.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 21st, 2022 01:02PM Aug 21st, 2022 01:02PM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 20th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 68.0 52.0 54.0 55.0 60.0 65.0 95.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 20th, 2022 02:39PM Aug 20th, 2022 02:39PM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 19th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 68.0 52.0 54.0 55.0 60.0 65.0 95.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 38.00 FAVORABLE Aug 19th, 2022 01:02PM Aug 19th, 2022 01:02PM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 18th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 68.0 52.0 54.0 55.0 60.0 65.0 95.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 37.00 FAVORABLE Aug 18th, 2022 04:45AM Aug 18th, 2022 04:45AM Insulet Health Care Health Care Equipment & Services
nasdaq:podd https://www.indeed.com/cmp/insulet-corporation Aug 17th, 2022 12:00AM Open Insulet Corporation Pharmaceutical & Biotechnology Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod® product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod, by tailoring its Omnipod® technology platform for the delivery of non-insulin subcutaneous drugs across multiple therapeutic areas. Founded in 2000, more than 140,000 users across the globe rely on Insulet’s Omnipod® Insulin Management System to bring simplicity and freedom to their lives. On July 1, 2018, Insulet assumed direct distribution of its Omnipod® Insulin Management System in Europe, including sales, marketing, training and customer support activities. This allows Insulet to be closer to the diabetes community and identify opportunities to support European customer needs over the long-term, as it does in the United States and Canada. European customers can find additional information about our transition at www.omnipodeurope.com and can also register for email updates. RRv1_100M_500M Insulet Corporation 600 Technology Park Drive Billerica, MA 01821 Shacey Petrovic 3.10 58.0 57.0 60.0 59.0 57.0 55.0 53.0 68.0 52.0 54.0 55.0 60.0 65.0 95.0 138.00 138.00 2.60 3.50 2.60 2.40 2.80 35.00 About a day or two 41.00 EASY 37.00 FAVORABLE Aug 17th, 2022 10:24AM Aug 17th, 2022 10:24AM Insulet Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.